Condition: Decompensated Cirrhosis · Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER)
This is a phase III, multicenter, double-blind, placebo-controlled, randomized clinical trial to evaluate the safety and efficacy of Fecal Microbiota Transplantation (FMT) from healthy subjects to patients with decompensated cirrhosis.
This description comes directly from the study's public registry record.
Eva Bonfill · +34932275400 · BONFILL@recerca.clinic.cat
Always discuss trial participation with your own doctor first.
| Hospital Clínic de Barcelona | Barcelona, Spain | Recruiting |
| Hospital de la Santa Creu i Sant Pau | Barcelona, Spain | Recruiting |
| Hospital Universitari Vall Hebron | Barcelona, Spain | Recruiting |
| Hospital General Universitario Gregorio Marañón | Madrid, Spain | Recruiting |
| Hospital General Universitario Puerta de Hierro | Madrid, Spain | Recruiting |
| Hospital Universitario Ramón y Cajal | Madrid, Spain | Recruiting |
| Corporació Sanitaria Universitaria Parc Taulí | Sabadell, Spain | Recruiting |
| Hospital Universitario Marqués de Valdecilla | Santander, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06533852